Novartis Institutes for BioMedical Research, CPP and Compound Bank Laboratory Renovation
Each phase of this three-and-a-half-year endeavor could be considered a project in its own right. It required careful planning and meticulous coordination with Norvatis’s design team and numerous equipment vendors. After completing preconstruction, DCBA made MEP, infrastructure, and architectural upgrades to an extant laboratory space so that the occupants of the area that would become the new Compound Bank Laboratory could relocate with little interruption to work as usual. Once the user-group was fully moved into the renovated laboratory, workers began converting the space into the Compound Bank Laboratory, which would be used to store millions of compounds that are essential for research and production. This phase had two major challenges. First, it was imperative that all work did not impact the existing Compound Bank, which was located in the lab directly adjacent to the construction area. Second, because the new Compound Bank included custom European equipment, DCBA had to be in continuous communication with equipment vendors to ensure that the correct MEP infrastructures were in place before equipment arrived on site. DCBA worked closely with the design team to make sure that code requirements were met. In addition to all new MEP systems, DCBA created a fully equipped research laboratory, a custom cold room with automatic robots, and a custom FM Fire Protection System in the Tubestore Equipment. The DCBA project team returned to make modifications as design plans were altered and performed commissioning. DCBA also assisted in the SAT final acceptance testing before moving onto the final phases, which included the demolition and removal of the original Compound Bank equipment. Architectural and MEP repairs and terminations were completed once equipment was safely removed.